Overview
Pamela Rabbitts practices practicing medicine in Leeds, United Kingdom.
Her clinical expertise encompasses Human Papillomavirus Infection and Squamous Cell Lung Carcinoma.
She is actively involved in clinical research, co-authoring 23 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Pamela H. Rabbitts
Is Pamela H. Rabbitts a top-rated expert for Human Papillomavirus Infection?
MediFind is an objective health platform that identifies experts based on real-world data. Pamela H. Rabbitts is classified as an Experienced expert for Human Papillomavirus Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Pamela H. Rabbitts participate in research or clinical trials?
Yes. Pamela H. Rabbitts has published 23 articles and abstracts on conditions like Human Papillomavirus Infection. You can view a list of Pamela H. Rabbitts's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Human Papillomavirus InfectionMs. Rabbitts isExperienced. Learn about Human Papillomavirus Infection.
- Squamous Cell Lung CarcinomaMs. Rabbitts isExperienced. Learn about Squamous Cell Lung Carcinoma.